Jeremy C. Lowe

Partner
(he, him, his)
Contact
P 816.292.8154 | F 816.474.3216
Spencer Fane attorney Jeremy Lowe

Overview

Jeremy Lowe represents clients in high-stakes patent trials and appeals and other complex litigation matters with a focus on pharmaceuticals and medical devices. Boasting more than 24 years of experience as a trial and appellate attorney, he works with both plaintiffs and defendants in state and federal courts to consistently achieve favorable outcomes.

Recognized for his exceptional legal acumen, Jeremy has successfully represented clients before multiple U.S. district courts, the U.S. Patent and Trademark Office, the U.S. Court of Appeals for the Federal Circuit, and the U.S. Supreme Court. His notable victories include defending a multibillion-dollar jury trial and achieving a landmark ruling that reshaped 150 years of double patenting law.

Jeremy’s undergraduate degree in chemical engineering and capacity to understand high-level STEM materials have laid the foundation for exceptional legal services and outcomes. He prioritizes honest and transparent communication with clients, proactive and ethical legal strategies, professional relationship maintenance with opposing counsel, and winning by all means necessary.

Credentials

Education

  • Washington University in St. Louis School of Law, 1999 (J.D.)
  • University of Missouri – Columbia, 1996 (B.S.)

Bar Admissions

  • Missouri
  • Illinois
  • Connecticut
  • New York
  • U.S. Patent and Trademark Office

Court Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals for the Federal Circuit

  • Successfully defended a leading industry client in a $100 million+ patent infringement trial against a top film manufacturer involving photosensitive films.
  • Represented a global pharmaceutical company in a multibillion-dollar patent infringement trial over anti-seizure medications.
  • Secured a summary judgment of patent infringement for a pharmaceutical company in a sleep medication dispute.
  • Defended a Fortune 100 company in a $30 million+ antitrust and patent infringement trial involving respirator technology.
  • Represented a global pharmaceutical company in a patent infringement trial concerning sterile solution formulations.
  • Advocated for an international pharmaceutical company in a patent infringement case involving gastric retention formulations.
  • Represented a global pharmaceutical company in a patent infringement trial over oral film technologies.
  • Represented an international pharmaceutical company in a trial before the Patent Trial and Appeal Board involving anti-fungal compounds.
  • Secured summary judgment in a patent infringement case for an international pharmaceutical company regarding anti-viral medications.
  • Successfully negotiated settlement in a patent infringement matter involving cancer treatment drugs for a global pharmaceutical company.
  • Represented a Fortune 50 company at the Federal Circuit in a case involving medical implant technologies.
  • Advocated for a pharmaceutical company at the Federal Circuit in a landmark anti-viral medication case reshaping 150 years of double patenting law.
  • Represented a global pharmaceutical company at the Federal Circuit in an appeal involving sleep medication patents.
  • Defended a pharmaceutical company at the Federal Circuit in a case over oral film formulations.
  • Represented international clients as amici in three Federal Circuit appeals addressing double patenting law.
  • Represented international client at the Supreme Court in response to a cert. petition.

  • Girls and boys youth athletics and team sports, head coach

  • Litigation Counsel of America, Order of Certus, Barrister
  • Martindale-Hubbell Peer Review, AV Preeminent
  • University of Missouri, Academy of Distinguished Alumni, Chemical Engineering, Fellow
  • Chambers USA, Recognized Practitioner, 2016
  • Hartford Business Journal, Top 40 Under 40 Business Leaders, 2013
  • Connecticut Law Tribune, New Leaders in the Law, 2012
  • Connecticut Magazine, Top 40 Under 40 People, 2012

  • Trial Law Institute
  • Diversity Law Institute

  • “What’s Happening with Double Patenting After Allergan,” 14th Annual Pharma IPR India Conference, Mumbai, March 2025
  • “Dissecting the Obviousness-Type Double Patenting Debate,” Law360, November 2024